Revance Therapeutics Inc (RVNC)
2.65
-0.22
(-7.67%)
USD |
NASDAQ |
Jun 21, 16:00
2.81
+0.16
(+6.04%)
Pre-Market: 08:26
Revance Therapeutics Total Return Level: 2.65 for June 21, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
June 21, 2024 | 2.65 |
June 20, 2024 | 2.87 |
June 18, 2024 | 2.80 |
June 17, 2024 | 2.80 |
June 14, 2024 | 2.82 |
June 13, 2024 | 2.97 |
June 12, 2024 | 3.025 |
June 11, 2024 | 2.94 |
June 10, 2024 | 2.74 |
June 07, 2024 | 2.70 |
June 06, 2024 | 2.90 |
June 05, 2024 | 3.03 |
June 04, 2024 | 2.91 |
June 03, 2024 | 3.01 |
May 31, 2024 | 2.84 |
May 30, 2024 | 2.89 |
May 29, 2024 | 2.80 |
May 28, 2024 | 2.67 |
May 24, 2024 | 2.71 |
May 23, 2024 | 2.67 |
May 22, 2024 | 2.92 |
May 21, 2024 | 3.01 |
May 20, 2024 | 3.16 |
May 17, 2024 | 3.02 |
May 16, 2024 | 3.16 |
Date | Value |
---|---|
May 15, 2024 | 3.31 |
May 14, 2024 | 3.48 |
May 13, 2024 | 3.32 |
May 10, 2024 | 3.32 |
May 09, 2024 | 4.29 |
May 08, 2024 | 4.27 |
May 07, 2024 | 4.38 |
May 06, 2024 | 4.10 |
May 03, 2024 | 3.95 |
May 02, 2024 | 3.77 |
May 01, 2024 | 3.795 |
April 30, 2024 | 3.61 |
April 29, 2024 | 3.69 |
April 26, 2024 | 3.40 |
April 25, 2024 | 3.29 |
April 24, 2024 | 3.57 |
April 23, 2024 | 3.66 |
April 22, 2024 | 3.64 |
April 19, 2024 | 3.78 |
April 18, 2024 | 3.79 |
April 17, 2024 | 3.76 |
April 16, 2024 | 3.81 |
April 15, 2024 | 3.97 |
April 12, 2024 | 4.13 |
April 11, 2024 | 4.44 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
2.65
Minimum
Jun 21 2024
37.61
Maximum
May 09 2023
19.78
Average
20.30
Median
Total Return Level Benchmarks
AbbVie Inc | 272.28 |
Design Therapeutics Inc | 3.38 |
Humacyte Inc | 5.17 |
Context Therapeutics Inc | 2.16 |
AN2 Therapeutics Inc | 2.11 |